CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

NCT06399419 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Osel, Inc.

Collaborators